Trial Profile
A Comparison of Patients on AVAMYS Versus NASONEX (Schering Corporation) and FLIXONASE on Key Health Outcome Measures.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Sep 2023
Price :
$35
*
At a glance
- Drugs Fluticasone furoate (Primary) ; Fluticasone propionate; Mometasone
- Indications Seasonal allergic rhinitis
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 23 Sep 2010 New trial record